17. Warrants (Details) - Warrants [Member] - $ / shares |
3 Months Ended | |
|---|---|---|
Mar. 31, 2020 |
Dec. 31, 2019 |
|
| Warrants outstanding, beginning balance | 692,034 | |
| Warrants issued | 124,481 | |
| Warrants outstanding, ending balance | 816,515 | |
| Warrants exercisable, end of period | 815,515 | |
| Weighted average exercise price, beginning | $ 2.88 | |
| Weighted average exercise price, issued | 2.41 | |
| Weighted average exercise price, ending | $ 2.81 | |
| Weighted average exercise price, exercisable | $ 2.81 |
| X | ||||||||||
- Definition Warrants exercisable, end of period No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, exercisable No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|